Please Wait
Applying Filters...
menu
    • menu
    Tiefenbacher Group-PSE
    News
    Lindus Health, Tiefenbacher Group Launch ME/CFS Clinical Trial

    06 Mar 2025

    // PR NEWSWIRE

    Tiefenbacher Group Renovation Of Headquarters In Hamburg

    02 May 2024

    // PRESS RELEASE

    Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.

    09 Apr 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Tiefenbacher Group

    Contact Supplier

    Website

    IMCAS Asia

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
    Left Arrow
    Right Arrow

    We are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    Related CompaniesRelated Companies

    About

    Founded in 1963 as the world’s first exclusive agency for APIs, the Tiefenbacher Group has evolved into a leading healthcare company offering innovative solutions across the entire pharmaceutical value chain. Tiefenbacher distributes raw materials and excels in the development, manufacture and registration of FDFs, including tablets, capsules, powders, drops, patches and medical devices. Tiefenbacher offers integrated services like pharmaceutical distribution, supply chain management, contract manufacturing, regulatory consulting and market access support. It aims to provide affordable, high-quality healthcare solutions worldwide.